Insights & Publications

Sentri7 failed to detect at least five instances of surgical fentanyl diversion Wolters Kluwer’s Sentri7, an AI drug-monitoring software employed by over 700 hospitals, failed to detect five instances of fentanyl diverted by a nurse, John A. Stevenson, at Erlanger Baroness between March and June of 2025. Most concerningly, state and hospital officials only identified fentanyl diversions through a retrospective investigation and dedicated audit of Sentri7, which claims to moni

OpenEvidence's clinical AI product is used by over 40% of U.S. physicians, according to its own estimates Drama and accusations of impropriety in the world of agentic LLMs. After a study published in Nature claimed that on “500 MedQA questions testing medical knowledge, 500 HealthBench items measuring alignment with clinicians” and “100 de-identified queries from physicians [...] in a live clinical environment,” frontier LLMs like GPT 5.2 and Claude Opus 4.6 “outperformed cli

CHARGE Surge CHARGE Surge is your home for continuous monitoring of the security and integrity of AI deployment. A surge is a sudden spike in voltage across a circuit. CHARGE Surge monitors voltage spikes across the healthcare circuit, providing the information you need to track AI security breaches, system failures, and critical emergent research. SURGE: OpenEvidence lashes out at authors of Nature study which reported superior performance from frontier LLMs OpenEvidence's

Jason G. Cooper is an AI integration expert, formerly of Paradigm, HMS, and Blue Cross Blue Shield. CHARGE had the pleasure of speaking with Jason G. Cooper this past weekend in an interview that ranged from responsible AI deployment to NASA to the historical significance of the Dewey Decimal System. Throughout his career as a Chief Technology, Analytics, and AI Officer, Jason has managed the core data and analytics systems and teams for major health payers and providers, a

Dr. Shiv Rao, Abridge's founder and CEO. Abridge is evaluated at $5.3 billion. At a sweeping keynote address on June 11, Abridge announced a strategic partnership with NVIDIA’s Nemotron to train a frontier artificial intelligence model designed specifically for clinical conversations. The new AI model will ostensibly be tailor designed for Abridge’s new suite of expanded operations, which it claims provides support for physicians at all stages of service, by surfacing and gen

AI-powered genomic reanalysis is revolutionizing local diagnosis of genetic diseases. A recent study from Harvard Medical School, Boston Children’s Hospital and OpenAI offers a compelling argument for LLM integration in rare disease diagnosis. With AI-assisted genomic reanalysis, researchers identified 18 new local diagnoses across 376 previously unsolved cases spanning neurodevelopmental and neuromuscular diseases, early psychosis, and sudden unexpected pediatric deaths. Th

Most health systems have AI policies in place. But as AI becomes embedded in daily workflows, a growing share of use is happening quietly — outside formal approval pathways, and often beyond leadership’s visibility.

“99% accurate” may sound decisive, but in healthcare AI it tells only a fraction of the story. Real impact is determined less by model performance alone and more by whether organizations can operationalize the output within their own workflows, teams, and constraints.

In this interview, Dr. Alexandra Rabotin shares what ambient AI scribes look like in real clinical workflows, from bilingual encounters to safety-net settings.

A vascular surgeon’s view on the risks, opportunities, and governance of AI in clinical care.

From clinical decision support to enterprise automation, AI is reshaping healthcare, but who’s leading the charge? Meet the executives shaping the future of responsible AI in hospitals across the US

How do we move AI from promise to practice in healthcare? Dr. Sarah Gebauer unpacks what’s really holding systems back.

When AI harms, who’s to blame? As AI enters clinical care, liability is shifting. Here's what health leaders need to know.

Dr. Jan Clusmann on the Hidden Risks of AI Manipulation to Patient Safety

Helen Lu, a clinical informatics leader, discusses challenges small health systems face in adopting AI to enhance patient care.

Generative AI is reshaping healthcare. Dr. Eyal Klang shares how to harness it safely.

Learn how healthcare can navigate AI risks and build trust with expert insights from Mitch Kwiatkowski.

Dr. Deepti Pandita, CMIO at UCI Health, shares insights on driving safe and effective AI governance in healthcare.

Sam Khan explores the newly proposed HIPAA AI rule and its impact on healthcare AI compliance.

Explore the 2025 list of top Chief AI Officers shaping AI strategy, governance, and innovation in healthcare.